To further assesses the clinical usefulness of IL-18BP as a biomarker, we also investigated serum IL-18 levels, which had previously been reported to be useful as a clinical biomarker for IPF [16], in both IPF patients and HVs. The gene discussed is IL18BP; the disease is idiopathic pulmonary fibrosis.